Sofiterm Spółka z Ograniczoną Odpowiedzialnością (KRS 0000885939, NIP 6762593094) is a Polish company, headquartered in Kraków, Małopolskie voivodeship. SOFITERM operates in: Agents involved in the sale of a variety of goods (PKD 46.19.Z). Industry: Wholesale trade. The company has been listed in the National Court Register since February 25, 2021. SOFITERM's most recently reported net revenue was 11.6 M PLN for 2024.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Sofiterm
Identity
- Name
- Sofiterm Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- February 25, 2021
- Registry status as of
- December 3, 2025
- Latest entry
- May 26, 2025
- Founding act
- 24.02.2021
Articles of association history (1)
- February 24, 2021: 24.02.2021
Activities
Main activity
46.19.ZAgents involved in the sale of a variety of goods
Address and contact
- Address
- UL. ZAWIŁA, 56, 30-390, KRAKÓW, POLSKA
- Voivodeship
- MAŁOPOLSKIE
- District
- KRAKÓW
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-68849-36135-RSFDI-19
Risk and payment profile - Sofiterm
Credibility rating
71.5 / 100
Good credibility
Insolvency risk
Very low
Low threat
Closure risk
1
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/5 yrs
Board changes
0
0/5 yrs
PKD changes
0
0/5 yrs
Name changes
0
0/5 yrs
Data from 5 years of registry activity.
Credibility history
Payment reliability score from 2021–2024
Current: B (72/100)
Trend: stable (-0.2 pts/year)
High payment credibility - the company's financial condition is good and the risk of cooperating with it is low.
Trade credit limit history
Standard limit from 2021–2024
Current: 553.8 K PLN
Safe: 360.0 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Sofiterm
Founded
February 25, 2021
5 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
KRAKÓW
MAŁOPOLSKIE
Primary PKD
46.19.Z
Agents involved in the sale of a variety of goods
Share capital
5.0 K PLN
50 shares total
Shareholders
2
shareholders
Board
2 people
Filed years
4 years
2021–2024
Registry entries
10
latest: May 26, 2025
Revenue
11.6 M PLN
2024
Net profit
569.7 K PLN
2024
Assets
2.5 M PLN
2024
Equity
N/A
2024
EBITDA
620.9 K PLN
2024
Valuation
3.2 M PLN
Low confidence
Low confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Sofiterm.
No ratings
Related articles
Explainer
Eurocash in 2026: Polish FMCG-wholesale leader and Delikatesy Centrum network, an mWIG40 issuer near Poznań, controlled by Luis Amaral
Eurocash S.A. (KRS 0000213765), headquartered at ul. Wiśniowa 11 in Komorniki near Poznań, is the leader of Poland's FMCG-wholesale distribution and the operator of the 1,500+ Delikatesy Centrum store network. Founded in 1995 by Portuguese entrepreneur Luis Amaral, listed on the WSE since 2005, the company is an mWIG40 constituent. A six-member management board, a five-member supervisory board, chaired by the founder himself.
Explainer
Mercator Medical in 2026: a Kraków-based medical-glove producer with plants in Thailand, an mWIG40 issuer after the COVID meme-stock cycle
Mercator Medical S.A. (KRS 0000036244), headquartered at ul. Modrzejewskiej 30 in Kraków, is a Polish producer and distributor of single-use medical gloves (nitrile and latex) and other disposables. The company controls the full value chain: plants in Thailand (Mercator Medical Thailand) plus Polish and international distribution. In 2020 the share price exploded on pandemic demand (from PLN 10 to over PLN 800), followed by cautious normalisation. Listed on the WSE since 2013. A three-member management board, a five-member supervisory board.
